FISCAL NOTE

Date Requested: January 31, 2022
Time Requested: 02:18 PM
Agency: Insurance Commission
CBD Number: Version: Bill Number: Resolution Number:
1999 Introduced SB511
CBD Subject: Insurance


FUND(S):

7152 Insurance Commission Fund

Sources of Revenue:

Special Fund

Legislation creates:





Fiscal Note Summary


Effect this measure will have on costs and revenues of state government.


If enacted, Senate Bill 511 would prohibit insurers from denying prescription drugs for the mitigation of opioid withdrawal symptoms. Senate Bill 511 would have no fiscal impact on the Offices of the Insurance Commissioner. Please see the memorandum section of this fiscal note for additional information.



Fiscal Note Detail


Effect of Proposal Fiscal Year
2022
Increase/Decrease
(use"-")
2023
Increase/Decrease
(use"-")
Fiscal Year
(Upon Full
Implementation)
1. Estmated Total Cost 0 0 0
Personal Services 0 0 0
Current Expenses 0 0 0
Repairs and Alterations 0 0 0
Assets 0 0 0
Other 0 0 0
2. Estimated Total Revenues 0 0 0


Explanation of above estimates (including long-range effect):


Please explain increases and decreases in personal services, current expenses, repairs and alterations, assets, other costs and revenues, including assumptions and data sources and delineation between start-up and ongoing costs. Please also include a long-range schedule of costs and revenues if fiscal impact is expected to vary in future years.



Memorandum


If enacted, Senate Bill 511 would prohibit an insurance carrier or a Medicaid contracted managed care organization from denying prescription drugs for the mitigation of opioid withdrawal symptoms. Senate Bill 511 would have no fiscal impact on the Offices of the Insurance Commissioner. The WV Department of Heath and Human Resources (DHHR) should be contacted regarding any potential impact to the Medicaid system. It should be noted that SB 511 does not contain language limiting the insurance benefits provided under the bill to the essential health benefits (EHB) specified under section 130(b) of the Patient Protection and Affordable Care Act (PPACA). PPACA 1311 (d)(3) provides that a state must defray the cost by direct payment to enrollees or to the Plan of any state mandated benefit in excess of the EHB. To the extent that the health insurance benefits required by SB 511 do not fall within the EHB, a potential cost to the State exists.



    Person submitting Fiscal Note: Melinda Kiss
    Email Address: Melinda.A.Kiss@wv.gov